Articles written by matthew perrone
Sorted by date Results 26 - 50 of 135
By 
US opens COVID boosters to all adults, urges them for 50+
WASHINGTON (AP) — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans t...
Pfizer asks US officials to OK promising COVID-19 pill
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. The company's filing comes as new i...
Pfizer says COVID-19 pill cut hospital, death risk by 90%
WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the c...
FDA paves way for Pfizer COVID-19 vaccinations in young kids
WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and u...
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received i...
FDA panel endorses booster shot for J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands. J&J told the Food and Drug A...
Merck asks US FDA to authorize promising anti-COVID pill
WASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic. If cleared by the Food and Drug A...
Merck says COVID-19 pill cuts risk of death, hospitalization
WASHINGTON (AP) — In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half. If cleared by regulators, it w...
US panel backs COVID-19 boosters only for seniors, high-risk
WASHINGTON (AP) — Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those who a...
COVID-19 surge in the US: The summer of hope ends in gloom
WASHINGTON (AP) — The summer that was supposed to mark America's independence from COVID-19 is instead drawing to a close with the U.S. more firmly under the tyranny of the virus, with deaths per day back up to where they were in March. The delta var...
Efforts grow to stamp out use of parasite drug for COVID-19
WASHINGTON (AP) — Health experts and medical groups are pushing to stamp out the growing use of a decades-old parasite drug to treat COVID-19, warning that it can cause harmful side effects and that there's little evidence it helps. With a fourth w...
US regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations m...
Demand for COVID antibody drugs soars in hard-hit states
People infected with COVID-19 were captured in a photo this week lying on the floor in pain while waiting for antibody infusions at a treatment site set up inside the library in Jacksonville, Florida. The image has become a vivid illustration of the...
More protection: US likely to authorize COVID booster shots
WASHINGTON (AP) — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots to gain longer-lasting protection as the d...
FDA adds warning about rare reaction to J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. The Food a...
FDA adds warning about rare reaction to J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. The Food a...
US agency says women can get abortion pill via mail
WASHINGTON (AP) — Women seeking an abortion pill will not be required to visit a doctor's office or clinic during the COVID-19 pandemic, U.S. health officials said Tuesday in the latest reversal in an ongoing legal battle over the medication. The F...
US advisers endorse single-shot COVID-19 vaccine from J&J
WASHINGTON (AP) — U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic. The Food and Drug Administration is expected to q...
Drug executives: Big jump in vaccine supply is coming soon
WASHINGTON (AP) — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer. V...
FDA says single-dose shot from J&J prevents severe COVID
WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to h...
Calls grow for US to rely on rapid tests to fight pandemic
WASHINGTON (AP) — When a Halloween party sparked a COVID-19 outbreak at North Carolina Agricultural and Technical State University, school officials conducted rapid screening on more than 1,000 students in a week, including many who didn't have sympt...
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day. Much-needed doses are set to arrive Monday a...
US vaccinations ramp up as 2nd COVID-19 shot nears
WASHINGTON (AP) — Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization. A day a...
Over-the-counter home test for COVID-19 gets US green light
WASHINGTON (AP) — The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves. U.S. regulators Tuesday authorized the rapid coronavirus test, which can be done entirely at home. The announcement by the F...
Over-the-counter home test for COVID-19 gets US green light
WASHINGTON (AP) — The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves. U.S. regulators Tuesday authorized the rapid coronavirus test, which can be done entirely at home. The announcement by the F...
